Invoking ‘Choice’ When Discussing Surrogacy as a Feminist Concern is a Mistake
By Susan Berke Fogel, Francine Coeytaux, Marcy Darnovsky, Lisa Ikemoto, and Judy Norsigian,
RH Reality Check
| 04. 23. 2014
It is troubling to see the vexing question of
commercial surrogacy treated as a litmus test for feminists at
RH Reality Check. While some lifelong supporters of women’s rights may see nothing problematic about contract pregnancy, others argue that it should be prohibited, and still others believe it should be allowed but
carefully regulated. Contract pregnancy can’t be understood in a simplistic
pro-choice versus anti-choice framework, or as only a matter of self-determination. Thirty years after “Baby M” and more than a decade after the emergence of a cross-border surrogacy industry, some of us are still unsure where we come down on commercial surrogacy. But it seems indisputable that the issue of contract pregnancy deserves careful thought.
We at the Pro-Choice Alliance for Responsible Research believe that social justice, safety, and human rights must be paramount in public policy and private practice in emerging biotechnologies, and we are striving to assess commercial surrogacy from that perspective. The surrounding quandaries are many and complex, especially for women working as surrogates and the children they bear, but also for commissioning...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...